Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason Alger currently holds 722,840 shares of Health Catalyst, Inc. (HCAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Alger has been a net seller of HCAT stock. They have purchased $0 and sold $613.4K worth of shares.
Jason Alger's most recent insider trade was on Jun 1, 2026, when they sold 18,804 shares at $1.37 per share.
Jason Alger serves as Executive at Health Catalyst, Inc. (HCAT). They have executed 48 insider transactions totaling $613.4K over their tenure at the company.
Jason Alger holds the position of Executive at Health Catalyst, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Jason Alger has shown a selling trading pattern, with $0 in total purchases and $613.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jason Alger was on Apr 13, 2021, when they sold $315.5K worth of HCAT shares. This transaction involved 6,301 shares at $50.07 per share.
Jason Alger currently owns 722,840 shares of Health Catalyst, Inc. (HCAT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason Alger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason Alger has 48 Form 4 filings on record as an insider at Health Catalyst, Inc..
Set alerts for Jason Alger and 40,000+ other insiders.